Geode Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Geode Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Buy	622,785 +23,174	+4%	+$103K	﹤0.01%	3161
2025 Q4	$2.98M	Buy	599,611 +92,634	+18%	+$404K	﹤0.01%	3014
2025 Q3	$1.6M	Buy	506,977 +144,777	+40%	+$397K	﹤0.01%	3259
2025 Q2	$819K	Sell	362,200 -406,766	-53%	-$1.16M	﹤0.01%	3395
2025 Q1	$2.05M	Buy	768,966 +13,121	+2%	+$40.8K	﹤0.01%	3017
2024 Q4	$2.66M	Buy	755,845 +6,736	+0.9%	+$30.5K	﹤0.01%	3030
2024 Q3	$3.55M	Buy	749,109 +48,474	+7%	+$221K	﹤0.01%	2927
2024 Q2	$3.29M	Buy	700,635 +493,851	+239%	+$2.38M	﹤0.01%	2941
2024 Q1	$940K	Buy	206,784 +21,859	+12%	+$97K	﹤0.01%	3384
2023 Q4	$762K	Hold	184,925	–	–	﹤0.01%	3452
2023 Q3	$795K	Buy	184,925 +22,637	+14%	+$114K	﹤0.01%	3420
2023 Q2	$842K	Sell	162,288 -18,195	-10%	-$128K	﹤0.01%	3418
2023 Q1	$1.23M	Buy	180,483 +95,118	+111%	+$452K	﹤0.01%	3249
2022 Q4	$210K	Sell	85,365 -189	-0.2%	-$485	﹤0.01%	4070
2022 Q3	$282K	Hold	85,554	–	–	﹤0.01%	4024
2022 Q2	$417K	Hold	85,554	–	–	﹤0.01%	3862
2022 Q1	$647K	Hold	85,554	–	–	﹤0.01%	3815
2021 Q4	$665K	Hold	85,554	–	–	﹤0.01%	3902
2021 Q3	$727K	Buy	85,554 +28,885	+51%	+$227K	﹤0.01%	3846
2021 Q2	$508K	Buy	56,669 +27,379	+93%	+$261K	﹤0.01%	3936
2021 Q1	$339K	Buy	+29,290	New	+$348K	﹤0.01%	3946
2020 Q3	–	Sell	-1,807	Closed	-$14K	–	4155
2020 Q2	$14K	Hold	1,807	–	–	﹤0.01%	4082
2020 Q1	$11K	Hold	1,807	–	–	﹤0.01%	4073
2019 Q4	$19K	Sell	1,807 -5	-0.3%	-$107	﹤0.01%	4162
2019 Q3	$61K	Buy	1,812 +43	+2%	+$1.69K	﹤0.01%	4039
2019 Q2	$68K	Hold	1,769	–	–	﹤0.01%	4025
2019 Q1	$114K	Buy	+1,769	New	+$71.5K	﹤0.01%	3866
2017 Q4	–	Sell	-67	Closed	-$27K	–	4023
2017 Q3	$27K	Hold	67	–	–	﹤0.01%	4000
2017 Q2	$53K	Sell	67 -2	-3%	-$1.62K	﹤0.01%	3945
2017 Q1	$67K	Hold	69	–	–	﹤0.01%	3900
2016 Q4	$75K	Hold	69	–	–	﹤0.01%	3840
2016 Q3	$76K	Hold	69	–	–	﹤0.01%	3857
2016 Q2	$151K	Buy	69 +17	+33%	+$35.5K	﹤0.01%	3678
2016 Q1	$77	Hold	52	–	–	﹤0.01%	3895
2015 Q4	$137K	Hold	52	–	–	﹤0.01%	3796
2015 Q3	$252K	Buy	52 +6	+13%	+$36.1K	﹤0.01%	3569
2015 Q2	$236K	Buy	46 +17	+59%	+$84.3K	﹤0.01%	3525
2015 Q1	$139K	Hold	29	–	–	﹤0.01%	3677
2014 Q4	$148K	Hold	29	–	–	﹤0.01%	3693
2014 Q3	$172K	Sell	29 -1	-3%	-$6.95K	﹤0.01%	3618
2014 Q2	$243K	Sell	30 -4	-12%	-$49.1K	﹤0.01%	3449
2014 Q1	$868K	Buy	34 +10	+42%	+$246K	﹤0.01%	2873
2013 Q4	$431K	Hold	24	–	–	﹤0.01%	3142
2013 Q3	$499K	Buy	24 +1	+4%	+$20.7K	﹤0.01%	2948
2013 Q2	$504K	Buy	+23	New	+$514K	﹤0.01%	2873

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management's ACHV Position: Q1 2026 in Review

Geode Capital Management increased its Achieve Life Sciences (ACHV) stake by 3.9% in Q1 2026, buying an estimated $103K and bringing the position to 622,785 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

Geode Capital Management first reported a position in ACHV in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.55M in Q3 2024. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Geode Capital Management held 622,785 shares of Achieve Life Sciences worth $1.83M as of Q1 2026.
Geode Capital Management bought 23,174 Achieve Life Sciences shares in Q1 2026, an estimated $103K.
Achieve Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3161 holding.
Geode Capital Management first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 45 quarters since.
Geode Capital Management's Achieve Life Sciences position peaked at $3.55M in Q3 2024.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.